Skip to content

Author

S. Sardari

We have 5 of 254 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Synthesis, in vitro and in silico studies of novel N-benzoyl EF24 analogs as potential anticancer agents.

INTRODUCTION EF24, a synthetic curcumin derivative, is effective against different forms of cancers but its derivatives are underdeveloped, particularly to improve cytotoxicity and drug-receptor interactions in colorectal cancer. AREAS COVERED Nine N-benzoyl EF24 analogs were prepared and identified by Fourier transf...

Fatemeh Khademi Moughari, Ramin Ebrahimi Kiasari, G. Ghavami et al. · 0 citations
Open access Sep 2026

Immune priming reprograms the maggot secretome to enhance anti-Leishmania activity

Cutaneous leishmaniasis remains a major unmet medical need due to treatment toxicity, emerging drug resistance, prolonged therapy, and persistent tissue damage. Lucilia sericata (Diptera: Calliphoridae) larvae are a promising source of bioactive secretions with antimicrobial and wound-healing properties. Here, we...

Azam Malekian, Naseh Maleki-Ravasan, S. Sardari et al. · 0 citations
Aug 2026

In Silico Discovery and in vitro Evaluation of the Antifungal and Cytotoxicity Properties of Zeaxanthin and β-Carotene

Findings suggest that Zeaxanthin and β-carotene, identified through a target-based chemoinformatics approach, could be considered as low-toxicity natural compounds with potential for topical or complementary applications in novel antifungal strategies.

Mohadese Panahi Moghadam, S. Sardari, Mohammad Norouzi Nejad et al. · 0 citations
Open access Sep 2026

Network analysis and drug repurposing reveal targets for combination therapy in drug resistant breast cancer

Multidrug resistance remains a major obstacle in cancer therapy and is driven by hyperactive efflux transporters and dysregulated signaling pathways. In this study, text mining and network analyses were performed to identify key genes associated with breast cancer drug resistance. Critical regulatory nodes were ide...

Najmeh. Fattahi, C. Eslahchi, F. Ghasemi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.